Clene Inc Market Cap ($16.72)
Market Cap & Net Worth: Clene Inc (CLNNW)
Clene Inc market cap. Clene Inc (NASDAQ:CLNNW) has a market capitalization of $16.72 ($16.72) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #32095 globally and #6495 in its home market, demonstrating a -66.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clene Inc's stock price $0.00 by its total outstanding shares 9291 (9.29K). Also see Clene Inc (CLNNW) cash flow conversion for how efficiently the company converts equity into cash flow.
Clene Inc Market Cap History (2018–2025)
Clene Inc market cap history from 2018 to 2025. Data shows change from $1.86K to $16.72 (-46.97% CAGR). Check Clene Inc share price for real-time trading data and today's change.
Clene Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clene Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Clene Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Clene Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $9.29K | $206.00K | -$19.28 Million | 0.05x | N/A |
| 2021 | $4.01K | $723.00K | -$9.74 Million | 0.01x | N/A |
| 2022 | $232.28 | $473.00K | -$29.92 Million | 0.00x | N/A |
| 2023 | $392.08 | $654.00K | -$49.50 Million | 0.00x | N/A |
| 2024 | $464.55 | $342.00K | -$39.40 Million | 0.00x | N/A |
Competitor Companies of CLNNW by Market Capitalization
Companies near Clene Inc in the global market cap rankings as of November 4, 2026. Also see total assets of Clene Inc for a full breakdown of the balance sheet.
Key companies related to Clene Inc by market ranking:
- Lion Financial Group Limited (NASDAQ:LGHLW): Ranked #32086 globally with a market cap of $29.69 USD.
- Advent Technologies Holdings Inc (NASDAQ:ADNWW): Ranked #32087 globally with a market cap of $28.31 USD.
- Jasmine International Public Company Limited (F:JASN): Ranked #32096 globally with a market cap of $16.05 USD ( €13.73 EUR).
- Lexaria Bioscience Corp (NASDAQ:LEXXW): Ranked #32097 globally with a market cap of $11.90 USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #32086 | Lion Financial Group Limited | NASDAQ:LGHLW | $29.69 | $0.00 |
| #32087 | Advent Technologies Holdings Inc | NASDAQ:ADNWW | $28.31 | $0.00 |
| #32096 | Jasmine International Public Company Limited | F:JASN | $16.05 | €0.00 |
| #32097 | Lexaria Bioscience Corp | NASDAQ:LEXXW | $11.90 | $0.00 |
Market Capitalization of Clene Inc (2018–2025)
Market capitalization of Clene Inc from 2018 to today. Between 2018 and today, Clene Inc's market cap moved from $1.86K to $ 16.72, with a yearly change of -46.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $16.72 | -96.40% |
| 2024 | $464.55 | +18.48% |
| 2023 | $392.08 | +68.80% |
| 2022 | $232.28 | -94.21% |
| 2021 | $4.01K | -56.79% |
| 2020 | $9.29K | +1563.89% |
| 2019 | $558.39 | -69.95% |
| 2018 | $1.86K | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Clene Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.72 USD |
| MoneyControl | $16.72 USD |
| MarketWatch | $16.72 USD |
| marketcap.company | $16.72 USD |
| Reuters | $16.72 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Clene Inc
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis … Read more